Louisiana State Employees Retirement System’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-5,840
| Closed | -$61.6K | – | 1528 |
|
|
2023
Q1 | $61.6K | Sell |
5,840
-113
| -2% | -$3.42K | ﹤0.01% | 1504 |
|
|
2022
Q4 | $202K | Sell |
5,953
-14
| -0.2% | -$678 | 0.01% | 1475 |
|
|
2022
Q3 | $286K | Sell |
5,967
-40
| -0.7% | -$2.38K | 0.01% | 1394 |
|
|
2022
Q2 | $339K | Buy |
6,007
+27
| +0.5% | +$1.7K | 0.01% | 1380 |
|
|
2022
Q1 | $418K | Buy |
5,980
+27
| +0.5% | +$4K | 0.01% | 1354 |
|
|
2021
Q4 | $1.21M | Buy |
5,953
+2,826
| +90% | +$613K | 0.03% | 787 |
|
|
2021
Q3 | $842K | Sell |
3,127
-26
| -0.8% | -$6.25K | 0.02% | 1007 |
|
|
2021
Q2 | $812K | Hold |
3,153
| – | – | 0.02% | 1032 |
|
|
2021
Q1 | $946K | Buy |
3,153
+166
| +6% | +$51.7K | 0.02% | 902 |
|
|
2020
Q4 | $762K | Buy |
2,987
+7
| +0.2% | +$1.81K | 0.02% | 921 |
|
|
2020
Q3 | $742K | Buy |
2,980
+20
| +0.7% | +$6.29K | 0.03% | 706 |
|
|
2020
Q2 | $1.03M | Buy |
2,960
+120
| +4% | +$37.4K | 0.06% | 377 |
|
|
2020
Q1 | $760K | Hold |
2,840
| – | – | 0.06% | 427 |
|
|
2019
Q4 | $920K | Buy |
+2,840
| New | +$824K | 0.05% | 576 |
|
|
2019
Q3 | – | Sell |
-580
| Closed | -$293K | – | 1438 |
|
|
2019
Q2 | $293K | Sell |
580
-33
| -5% | -$16.5K | 0.01% | 1250 |
|
|
2019
Q1 | $309K | Buy |
613
+6
| +1% | +$3.56K | 0.02% | 1253 |
|
|
2018
Q4 | $299K | Sell |
607
-66
| -10% | -$39.8K | 0.02% | 1203 |
|
|
2018
Q3 | $616K | Buy |
673
+40
| +6% | +$34.1K | 0.03% | 1035 |
|
|
2018
Q2 | $464K | Sell |
633
-20
| -3% | -$23.1K | 0.02% | 1188 |
|
|
2018
Q1 | $1.04M | Sell |
653
-3,860
| -86% | -$4.97M | 0.05% | 534 |
|
|
2017
Q4 | $4.04M | Buy |
4,513
+293
| +7% | +$173K | 0.18% | 83 |
|
|
2017
Q3 | $1.52M | Buy |
4,220
+7
| +0.2% | +$2.19K | 0.07% | 301 |
|
|
2017
Q2 | $1.24M | Buy |
4,213
+33
| +0.8% | +$9.54K | 0.06% | 387 |
|
|
2017
Q1 | $1.47M | Buy |
4,180
+87
| +2% | +$19.6K | 0.07% | 298 |
|
|
2016
Q4 | $753K | Buy |
4,093
+66
| +2% | +$13.4K | 0.04% | 720 |
|
|
2016
Q3 | $1.04M | Buy |
4,027
+7
| +0.2% | +$1.8K | 0.05% | 455 |
|
|
2016
Q2 | $858K | Buy |
4,020
+7
| +0.2% | +$1.56K | 0.05% | 575 |
|
|
2016
Q1 | $828K | Buy |
4,013
+80
| +2% | +$15.4K | 0.04% | 613 |
|
|
2015
Q4 | $994K | Buy |
3,933
+46
| +1% | +$9.46K | 0.05% | 494 |
|
|
2015
Q3 | $639K | Sell |
3,887
-6
| -0.2% | -$1.06K | 0.03% | 815 |
|
|
2015
Q2 | $731K | Buy |
+3,893
| New | +$670K | 0.03% | 788 |
|
Other funds holding NKTR
DTC
MAM
SCM
Louisiana State Employees Retirement System's NKTR Position: Q2 2023 in Review
Louisiana State Employees Retirement System sold out of Nektar Therapeutics (NKTR) in Q2 2023, closing a stake of 5,840 shares — an estimated $61.6K sold.
Louisiana State Employees Retirement System first reported a position in NKTR in Q2 2015 and held it in 31 quarters. The position peaked at $4.04M in Q4 2017. 146 funds tracked by Wall St. Rank hold NKTR as of Q2 2023.
- Louisiana State Employees Retirement System reported no remaining Nektar Therapeutics position as of Q2 2023 after selling out during the quarter.
- Louisiana State Employees Retirement System sold 5,840 Nektar Therapeutics shares in Q2 2023, an estimated $61.6K.
- Louisiana State Employees Retirement System first reported a position in Nektar Therapeutics in Q2 2015 and held it in 31 quarters.
- Louisiana State Employees Retirement System's Nektar Therapeutics position peaked at $4.04M in Q4 2017.
- 146 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q2 2023.
Based on Louisiana State Employees Retirement System's 13F filing for Q2 2023, filed 18 Jul 2023.